Back

Statin use after valvular heart surgery is associated with a decreased risk of prosthetic valve endocarditis

1 December 2022 (08:00 - 19:00)
Organised by:
Congress Presentation Part of: Valvular and Myocardial disease Prevention ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Doctor Qingwen Ren

The University of Hong Kong, Hong Kong (Hong Kong)

3 More presentations in this session

Presentation thumbnail
Different cellular landscape of four types of non-diseased cardiac valves contributes to their differences in susceptibility of pathological remodeling and disease
Doctor S. Shu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Natural history of functional mitral regurgitation: a systematic review and individual patient data meta-analysis
Mr Y. Teo (Singapore, SG)
Abstract Slides
Presentation thumbnail
Association of left atrial ejection fraction and cardiovascular outcomes in Asian patients with hypertrophic cardiomyopathy
Doctor N. Sari (Jakarta, ID)
Abstract Slides

Access the full session

Session thumbnail
Valvular and Myocardial disease

The Event

Event poster

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources